{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:59:05Z","timestamp":1790780345514,"version":"4.1.0"},"reference-count":62,"publisher":"Baishideng Publishing Group Inc.","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4254\/wjh.v9.i26.1092","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T06:00:25Z","timestamp":1505455225000},"page":"1092","source":"Crossref","is-referenced-by-count":140,"title":["Risk of liver disease in methotrexate treated patients"],"prefix":"10.4254","volume":"9","author":[{"given":"Richard","family":"Conway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm194806032382301"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(194909)2:53.0.CO;2-0"},{"key":"ref3","unstructured":"Food and Drug Administration. Methotrexate Prescribing Information. 2014; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/011719s117lbl.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/011719s117lbl.pdf<\/ext-link>."},{"key":"ref4","unstructured":"WHO. WHO Model List of Essential Medicines-19th List. 2015; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML_2015_FINAL_amended_NOV2015.pdf?ua=1\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/EML_2015_FINAL_amended_NOV2015.pdf?ua=1<\/ext-link>."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.37723"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1777"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.099861"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.38322"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1269"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.05.003"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.23736\/S0031-0808.16.03260-2"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:23.0.CO;2-8"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Wilke WS, Biro JA, Segal AM. Methotrexate in the treatment of arthritis and connective tissue diseases. Cleve Clin J Med 1987;54:327-338.","DOI":"10.3949\/ccjm.54.4.327"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Black RL, O\u2019brien WM, Vanscott EJ, Auerbach R, Eisen AZ, Bunim JJ. Methotrexate therapy in psoriatic arthritis; double-blind study on 21 patients. JAMA 1964;189:743-747.","DOI":"10.1001\/jama.1964.03070100037007"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200006013422202"},{"key":"ref16","unstructured":"Visser K, van der Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 2009;27:1017-1025."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22294"},{"key":"ref18","unstructured":"Ledingham J, Gullick N, Irving K, Gorodkin R, Aris M, Burke J, Gordon P, Cristidis D, Galloway S, Hayes E. BSR\/BHPR non-biologic DMARD Guidelines 2016. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.rheumatology.org.uk\/includes\/documents\/cm_docs\/2016\/f\/full_dmards_guideline_and_the_executive_summary.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.rheumatology.org.uk\/includes\/documents\/cm_docs\/2016\/f\/full_dmards_guideline_and_the_executive_summary.pdf<\/ext-link>."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360307"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196604)19:43.0.CO;2-3"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093690"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101378"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2136-8"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem279"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200107)44:73.0.co;2-7"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70365-3"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2004.01819.x"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0141076814562718"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13879"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02636.x"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802311"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.03.024"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn\u2019s disease: a randomised, investigator-blind study. Dig Liver Dis 2003;35:619-627.","DOI":"10.1016\/S1590-8658(03)00372-4"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150674"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.112136"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i46.17352"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i31.5131"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20897"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22428"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.","DOI":"10.1016\/S0016-5085(97)70183-5"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(98)11293-x"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22906"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-5-429"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1291-5"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004385.pub3"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20103"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933559"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2007.11.011"},{"key":"ref50","unstructured":"Knox TA, Kaplan MM. Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol 1991;86:546-552."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-231"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994;106:494-499.","DOI":"10.1016\/0016-5085(94)90610-6"},{"key":"ref53","unstructured":"Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Am J Gastroenterol 1996;91:511-515."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/art.38732"},{"key":"ref55","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019Donnell MJ, Carey JJ. Reply to: methotrexate and not much harm to the lungs by H. Yazici. Clin Exp Rheumatol 2014;32:S-11."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200004273421707"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094474"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.11.906"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370304"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel216a"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02071.x"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.9336"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i26\/1092.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T14:17:26Z","timestamp":1570112246000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v9\/i26\/1092.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":62,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v9.i26.1092","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}